SCHEMBL7536315

SCHEMBL7536315

Cc1ccc(C)c(OCc2ccccc2C(=O)c2ccon2)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.43
▸ NPC1 O15118 4/20 0.43
▸ KMT2A Q03164 5/20 0.42
▸ MEN1 O00255 4/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ MAPT P10636 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ SAE1 Q9UBE0 1/20 0.41
▸ UBA2 Q9UBT2 1/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ PTGDR2 Q9Y5Y4 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HIF1A Q16665 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7535399 0.83 RAB9A (0.39) RAB9ANPC1KMT2AMEN1ALDH1A1
SCHEMBL7537223 0.80 RAB9A (0.43) RAB9ANPC1KMT2AMEN1ALDH1A1
SCHEMBL7540548 0.78 MRGPRX4 (0.59) KMT2AMEN1ALDH1A1TSHRSMN1; SMN2
SCHEMBL7537186 0.77 PTGDR2 (0.50) RAB9ANPC1KMT2AMEN1ALDH1A1
SCHEMBL7535903 0.77 MAPT (0.42) RAB9ANPC1KMT2AMEN1ALDH1A1
SCHEMBL28816972 0.76 HTT (0.53) KMT2AMEN1ALDH1A1MAPTTSHR
SCHEMBL28832475 0.75 ALDH1A1 (0.46) RAB9ANPC1KMT2AMEN1ALDH1A1
SCHEMBL28001736 0.75 ALDH1A1 (0.50) KMT2AMEN1ALDH1A1MAPTTSHR
SCHEMBL3498068 0.74 SMN1; SMN2 (0.50) KMT2AMEN1ALDH1A1MAPTTSHR
SCHEMBL27814043 0.73 SMN1; SMN2 (0.51) RAB9ANPC1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6362212-B1 POTENT FUNGICIDAL ACTIVITY SHIONOGI & COMPANY, LTD. (JP) 2002-03-26 — — US disclosed
US-20020032227-A1 Oxime derivative and bactericide containing the same as active ingredient TAKASE AKIRA (JP) 2002-03-14 — — US disclosed
US-6268312-B1 FUNGICIDES SHIONOGI & CO., LTD. (JP) 2001-07-31 — — US disclosed
US-6048885-A FUNGICIDES SHIONOGI & CO., LTD. (JP) 2000-04-11 — — US disclosed
EP-0754684-A1 OXIME DERIVATIVE AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT SHIONOGI & CO., LTD. (JP) 1997-01-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032227-A1 Oxime derivative and bactericide containing the same as active ingredient MSMO1, O60361, CBR1 RAB9A 3734/4885NPC1 3604/4885KMT2A 1852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback